Ensefalopati Tablosuyla Gelen Leigh Sendromu

Yıl 2010, , 94 - 97, 01.04.2010

Belma Haliloğlu Atiye Fedakar

https://doi.org/10.5222/j.child.2010.094

Öz

Leigh sendromu mitokondriyal respiratuvar enzim zinci- rindeki kusur veya piruvat dehidrogenaz kompleksindeki yetersizlik sonucu beyin, beyin sapı ve omurilikte demyeli- nizasyon, gliozis, nekroz ve kapiller proliferasyonla karak- terize bir subakut nekrotizan ensefalomyelopati tablosudur. Çoğunlukla infantil tipi görülmekle beraber çocukluk ve erişkin tipleri de bulunmaktadır. Genetik geçiş biyokimya- sal defekte göre heterojenite gösterir. Klinik bulguları arasında artmış laktata bağlı letarji, beslenme azlığı, taşipne gibi nonspesifik bulgular, gelişme geriliği, hipoto- ni, intermittan ataksi, anormal göz hareketleri ve nöbetler yer alır. Bu yazıda ensefalopati tablosuyla başvuran Leigh sendromu tanısı alan 3 aylık bir vakamızda olduğu gibi özellikle sütçocukluğu döneminde metabolik tarama nor- mal gelse bile doğumsal metabolik hastalıkların akıldan çıkarılmaması gerektiğini vurgulamak istedik

Anahtar Kelimeler

Leigh’s sendromu, ensefalopati, metabolik hastalık

Leigh’s Syndrome Presenting with Encephalopathy

Öz

Leigh’s Syndrome is a subacute necrotizing encefalomyelo- pathy characterized by capillary proliferation, necrosis, gliosis, demyelinisation of brain, spinal cord, medulla oblongata, pons and mesencephalon. It’s caused by a defi- ciency in mitochondrial respiratory enzyme cycles or defi- ciency of an enzyme called pyruvate dehydrogenase. Usually infantile type is seen but childhood and adult types are present too. Genetic inheritance is heterogenic due to biochemical deficiency. Seizures, abnormal eye move- ments, intermittent ataxia, hypotonia, growth disorder, and some nonspecific findings; lethargy, lack of feeding, tachy- pnea due to increased lactate are some of the clinical fin- dings. We emphasized that, even if metabolic screening test results are normal, inherited metabolic diseases as seen in our case should be kept in mind

Anahtar Kelimeler

Leigh’s syndrome, encephalopathy, metabolic diseases

Kaynakça

• 1. Leigh D. Sub acute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951; 14:216-21.
• 2. Richter RB. Infantile subacute necrotizing encephalopathy (Leigh’s Disease): its relationship to Wernicke’s encephalopathy. Neurology 1968; 18:1125.
• 3. Montpetit VJA, Anderman F, Carpenter S, ZborowskaSluis D, Giberson HR. Subacute necrotizing encephalmyelopathy. Brain 1971; 94:1-30.
• 4. Barnes LA, Barnes EG. Metabolic diseases. In: Barnes EG, ed. Potter’s Pathology of the Fetus and Infant. St. Louis; Mosby Co 1997; 623-4.
• 5. Pincus JH. Subacute necrotizing encephalopathy (Leigh’s Disease): a consideration for clinical features and etiology. Dev Med Child Neurol 1972; 14:78-87.
• 6. Chen Y. Defects in metabolism of carbohydrate. In: Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: Saunders 2004: p.479-80.
• 7. Sarnat HB. Metabolic myopathies. In: Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: Saunders 2004: p.2072.
• 8. Johnston MV. Encephalopathies. In: Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: Saunders 2004: p.2027.
• 9. Naito E, Ito M, Yokota I, Saijo T, Ogawa Y, Kuroda Y. Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 2002; 201(1-2):33-7.
• 10. Stacpoole PW, Barnes CL, Hurbanis MD, et al. Treatment of congenital lactic acidosis with dichloroacetate. Arch Dis Child 1997; 77(6):535-41.
• 11. Fouque F, Brivet M, Boutron A, et al: Differential effect of DCA treatment on the pyruvate dehydrogenase complex in patients with severe PDHC deficiency. Pediatr Res 2003; 53(5):793-9.